Carolinas Wealth Consulting LLC Novartis Ag Transaction History

Carolinas Wealth Consulting LLC

  • $557 Million
  • Q4 2024

A detailed history of Carolinas Wealth Consulting LLC transactions in Novartis Ag stock. As of the latest transaction made, Carolinas Wealth Consulting LLC holds 198 shares of NVS stock, worth $21,593. This represents 0.0% of its overall portfolio holdings.

Number of Shares
198
Previous 198 -0.0%
Holding current value
$21,593
Previous $22,000 13.64%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
SELL
$106.13 - $120.89 $2,653 - $3,022
-25 Reduced 11.21%
198 $22,000
Q2 2024

Aug 12, 2024
BUY
$92.57 - $107.37 $833 - $966
9 Added 4.21%
223 $23,000
Q1 2024

May 14, 2024
BUY
$95.27 - $108.47 $3,620 - $4,121
38 Added 21.59%
214 $20,000
Q3 2023

Nov 14, 2023
SELL
$94.73 - $105.13 $22,261 - $24,705
-235 Reduced 57.18%
176 $17,000
Q2 2023

Aug 14, 2023
SELL
$92.52 - $104.91 $37,563 - $42,593
-406 Reduced 49.69%
411 $41,000
Q1 2023

May 15, 2023
BUY
$80.03 - $92.81 $32,572 - $37,773
407 Added 99.27%
817 $75,000
Q4 2022

Feb 14, 2023
BUY
$75.55 - $92.52 $3,022 - $3,700
40 Added 10.81%
410 $37,000
Q2 2022

Aug 16, 2022
BUY
$80.52 - $93.75 $17,714 - $20,625
220 Added 146.67%
370 $31,000
Q4 2021

Feb 14, 2022
BUY
$79.7 - $88.13 $5,579 - $6,169
70 Added 87.5%
150 $13,000
Q1 2021

May 17, 2021
BUY
$83.5 - $98.47 $6,680 - $7,877
80 New
80 $7,000
Q4 2020

Feb 16, 2021
SELL
$78.07 - $94.43 $14,442 - $17,469
-185 Closed
0 $0
Q3 2020

Nov 12, 2020
SELL
$82.14 - $91.0 $2,053 - $2,275
-25 Reduced 11.9%
185 $16,000
Q2 2020

Aug 13, 2020
BUY
$80.93 - $91.1 $16,995 - $19,131
210 New
210 $18,000

Others Institutions Holding NVS

# of Institutions
1,479
Shares Held
134M
Call Options Held
1.31M
Put Options Held
1.56M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $235B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Carolinas Wealth Consulting LLC Portfolio

Follow Carolinas Wealth Consulting LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Carolinas Wealth Consulting LLC, based on Form 13F filings with the SEC.

News

Stay updated on Carolinas Wealth Consulting LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email